Cellular retinaldehyde-binding protein (CRALBP) functions in the retinal pigment epithelium (RPE) as an acceptor of 11-cis-retinol in the isomerization step of the rod visual cycle and as a substrate carrier for 11-cisretinol dehydrogenase. Toward a better understanding of CRALBP function, the ligand binding cavity in human recombinant CRALBP (rCRALBP) was characterized by photoaffinity labeling with 3-diazo-4-keto-11-cis-retinal and by high resolution mass spectrometric topological analyses. Eight photoaffinity-modified residues were identified in rCRALBP by liquid chromatography tandem mass spectrometry, including Multiple different adduct masses were found on the photolabeled residues, and the molecular identity of each modification remains unknown. Supporting the specificity of photolabeling, 50% of the modified residues have been associate with retinoid interactions by independent analyses. In addition, topological analysis of apo-and holorCRALBP by hydrogen/deuterium exchange and mass spectrometry demonstrated residues 198 -255 incorporate significantly less deuterium when the retinoid binding pocket is occupied with 11-cis-retinal. This hydrophobic region encompasses all but one of the photolabeled residues. A structural model of CRALBP ligand binding domain was constructed based on the crystal structures of three homologues in the CRAL-TRIO family of lipid-binding proteins. In the model, all of the photolabeled residues line the ligand binding cavity except Met 208 , which appears to reside in a flexible loop at the entrance/exit of the ligand cavity. Overall, the results expand to 12 the number of residues proposed to interact with ligand and provide further insight into CRALBP ligand and protein interactions.
1 is a 36-kDa water soluble protein with a high affinity binding pocket for retinoids uniquely associated with vision, namely 11-cisretinal and 11-cis-retinol (1) . Human CRALBP gene defects can either tighten or abolish retinoid interactions, which in turn can compromise substrate carrier interactions with 11-cis-retinol dehydrogenase and lead to several retinal pathologies (2). Targeted disruption of the CRALBP gene in mice impairs regeneration of both rod and cone visual pigments (3) . These and other studies establish multiple functions for CRALBP in the retinal pigment epithelium (RPE), including roles as a major acceptor of 11-cis-retinol in the isomerization step of the rod visual cycle and as a facilitator of oxidation of 11-cis-retinol to 11-cis-retinal by 11-cis-retinol dehydrogenase (2-6). Ongoing proteomic studies support the existence of a RPE retinoid processing protein complex containing CRALBP (7) . Direct CRALBP interactions have been demonstrated in vitro with 11-cis-retinol dehydrogenase (2) and with ERM (ezrin, radixin, moesin)-binding phosphoprotein 50 (EBP50), also known as sodium hydrogen exchanger regulator factor type 1 (NHERF-1) (8) . Interactions with EBP50 have been suggested as a mechanism for localizing CRALBP to the apical RPE plasma membrane for export of 11-cis-retinal to the adjacent rod photoreceptor cells for visual pigment regeneration (8) . The functions of CRALBP in tissues other than the RPE remain to be determined (i.e. in retinal Mü ller cells, ciliary epithelium, iris, cornea, pineal gland, and a subset of oligodendrocytes of the optic nerve and brain).
To better understand CRALBP visual cycle functions, which require rapid association and dissociation of retinoid, we are characterizing the structure of the ligand binding pocket. Ligand interactions in CRALBP are non-covalent and previous structure-function studies (2, 9, 10) have implicated eight residues as possibly interacting with retinoid ( Fig. 1) . In this report, the interaction between human recombinant CRALBP and retinoid were characterized by mass spectrometry using hydrogen/deuterium exchange and photoaffinity labeling with 3-diazo-4-keto-11-cis-retinal (DK-11-cis-retinal). This photoaffinity analogue of 11-cis-retinal has previously been used to map the movement of ligand within rhodopsin following sensi- Tables I and II. ¶ This work was submitted in partial fulfillment of the requirements for a doctoral degree in chemistry from Cleveland State University.
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To further evaluate ligand interactions proposed from photoaffinity labeling and other biochemical analyses, we have generated a structural model of the CRALBP ligand binding domain. CRALBP belongs to the CRAL-TRIO protein family (13) and shares 20 -33% sequence identity with conserved regions of three cytosolic lipid-binding proteins for which high resolution crystal structures are available. Our model of CRALBP is based on the crystal structures of homologues human ␣-tocopherol transfer protein (␣TTP) (14, 15) , yeast Sec 14, a phosphatidylinositol-binding protein (16) , and human supernatant protein factor (SPF) (17) . The structural model supports ligand interactions with the photolabeled residues and provides further insight into CRALBP ligand and protein interactions.
EXPERIMENTAL PROCEDURES
Materials-11-cis-retinal was obtained from the NEI, National Institutes of Health. The photoaffinity reagent DK-11-cis-retinal was a generous gift from Professor Koji Nakanishi, Columbia University (11, 12) .
Production of rCRALBP-Wild-type human recombinant CRALBP (rCRALBP) was expressed in Escherichia coli strain BL21(DE3)LysS with an N-terminal His tag and apo-rCRALBP was purified to apparent homogeneity by nickel affinity chromatography (10, 18) . Unless otherwise noted, protein in the first five nickel affinity chromatography fractions (0.5 ml each) was pooled for the present structure-function study.
Amino Acid Analysis, Electrophoresis, and Protein QuantificationPhenylthiocarbamyl amino acid analysis was performed using an Applied Biosystems model 420H/130/920 automated analysis system (19) . SDS-PAGE was performed according to Laemmli (20) on acrylamide gels using a Mini-Protein II system (Bio-Rad). rCRALBP was quantified by amino acid analysis or according to Bradford (21) using rCRALBP previously quantified by amino acid analysis as the standard reference protein (10) .
Non-covalent Retinoid Labeling of rCRALBP-Purified aporCRALBP was labeled with retinoid (DK-11-cis-retinal or 11-cis-retinal) using 1.2-fold molar excess retinoid over rCRALBP and excess retinoid was removed by Sephadex G25 spin chromatography (10) . Retinoid binding properties were characterized by scanning UV-visible spectroscopy with a Hewlett Packard 8453 diode array spectrophotometer (10) . All retinoid labeling and analysis procedures were performed in red light. Bleaching was by exposure to ambient white light for 20 min at 4°C.
Photoaffinity Labeling of rCRALBP-rCRALBP with noncovalently bound DK-11-cis-retinal in 50 mM Tris-HCl pH 7.2 containing 1 mM dithiothreitol-EDTA, 67% glycerol was placed in the wells of a 24-well tissue culture plate (Model 5243, Corning Inc.) in the dark. The wells were partially immersed in liquid nitrogen and photolysis was performed at 254 nm for 5 s to 20 min with an 18.4 watt UV lamp (Model UVG-11, UVP, Inc., Upland, CA) held 2 cm above the plate. Photolysis was terminated by transferring the preparation from the plate to a tube and immediately extracting unbound retinoid 3ϫ with hexane (2:1, v/v). Glycerol was removed by Centricon centrifugation (Ultrafree 5-kDa cutoff, Millipore, Bedford, MA), the photolabeled protein (DKrCRALBP) concentrated by vacuum drying, then redissolved in 100 mM ammonium bicarbonate pH 8.0 containing freshly deionized 8 M urea. 8 .0, at 37°C. Tryptic digests were fractionated by RP-HPLC using the Applied Biosystem Model 120 HPLC system as described for the intact protein. One hundred chromatography fractions (ϳ100 l each) were collected, radioactivity was measured, and four separate radioactive pools were prepared. The radioactive pooled fractions and all other tryptic peptide fractions were dried in a SpeedVac, redissolved in 2% acetonitrile, 0.1% formic acid (15 l) for LC MS/MS analysis with a quadrupole time-of-flight mass spectrometer equipped with a CapLC (QTOF2, Waters Corporation, Milford, MA). Each sample (10 l) was injected onto a Pepmap C 18 trapping column (300 Å, 0.3 ϫ 1 mm, LC Packings Inc., San Francisco, CA). Peptides were gradient-eluted and separated on a C 18 capillary column (300 Å, 75 ϫ 5 cm, New Objective, Woburn, MA) at a flow rate of 270 nl/min after splitting the pump eluents after mixing (30:1). Solvent A consisted of 0.1% formic acid and 2% acetonitrile, and solvent B consisted of 0.1% formic acid and 98% acetonitrile. The QTOF2 mass spectrometer was operated in standard data-dependent acquisition mode using survey scans over 300 -2000 m/z acquired in 1.0 s followed by MS/MS over 50 -1900 m/z in 2.1 s and with 0.1 s between survey scans (23) . The capillary temperature was set at 120°C, the voltage at 2.5 kV, and a collision energy profile of 25-55% was used for peptide fragmentation with argon. MS/MS data were searched against SwissProt or NCBI sequence databases utilizing Proteinlynx Global Server version 1.0 and Proteinlynx version 3.5 (23) . All MS/MS spectra of photoaffinity-modified peptides were manually examined to confirm sequences.
Hydrogen/Deuterium Exchange and LC ESMS Analysis of Intact rCRALBP-Purified apo-or holo-rCRALBP with bound 11-cis-retinal (100 pmol) was equilibrated in 5 mM phosphate buffer pH 6.9 by buffer exchange using a Centricon (Ultrafree, 5-kDa cutoff) at room temperature. The apo-and holo-proteins were diluted 20-fold with D 2 O 5 mM phosphate buffer pD 6.9 (200 l) and incubated for 5-60 s at room temperature. HCl (0.1 M, 14 l) was added to lower the pD to 2.5, and the samples were placed in dry ice to quickly quench hydrogen/deuterium (H/D) exchange. The optimum reaction time with deuterium was determined by LC ESMS analysis of the intact proteins with a PerkinElmer Sciex API 3000 mass spectrometer equipped with an Applied Biosystems Model 140D HPLC system, and a 5 Vydac C 4 column (300 Å, 1.0 ϫ 50 mm). For these analyses, aqueous trifluoroacetic acid/acetonitrile solvents were used at 0°C, with a gradient of 30 -60% acetonitrile over 5 min, and a flow rate of 30 l/min (24) . All H/D-exchanged samples were stored at Ϫ80°C until analysis. Deuterium concentration measurements (pD) were from pH meter readings (2, 9, 10) . Boxed residues denote the location of disease-causing mutations. Residues 1-119 and 314 -316 (underlined) maybe be removed by limited proteolysis without disrupting retinoid binding (42) . The His tag fusion sequence is shown in italics, and asterisks denote photoaffinity-modified residues identified in the present report.
without correction for isotope effects. Holo-rCRALBP was maintained in the dark or under red illumination prior to LC ESMS or peptic digestion.
Pepsin Digestion-Prior to H/D exchange analyses of rCRALBP peptides, the pepsin fragmentation pattern of rCRALBP (100 pmol) was determined (25) . For these analyses, pepsin digestion was performed under conditions that limited back exchange of deuterium for hydrogen, namely 0°C, pH 2.5, pepsin:rCRALBP 2:1 (w/w), and 5 min of digestion time (24) . Immediately following digestion, peptides were subjected to LC MS/MS analysis using the above QTOF2 mass spectrometer equipped with an Applied Biosystems Model 140D HPLC system, a 5-Vydac C 18 column (300 Å, 1.0 ϫ 50 mm), aqueous formic acid solvents at 0°C and gradient elution of 2-60% acetonitrile over 60 min. The QTOF2 mass spectrometer was operated with capillary and cone voltages set to 3 kV and 45 V, respectively, and in the standard data-dependent acquisition mode as described above. In addition, the "include function" was employed to sequence minor peptides, which were not detected by the standard analysis program (26) . Peptides were identified using Proteinlynx Global Server version 1.0 and Proteinlynx version 3.5 to search an in-house sequence data base containing about 1000 protein entries including human rCRALBP.
Hydrogen/Deuterium Exchange and LC MS/MS Analysis of rCRALBP Peptides-H/D exchange, pepsin digestion, and LC MS/MS of peptic peptides were performed as described above with the following additions. Experiments were performed in duplicate for both apo-and holo-rCRALBP using 20-s deuterium incubation times and with protein isolated only in nickel affinity chromatography fraction 3. To minimize back-exchange of deuterium, a shorter HPLC gradient of 10 -40% acetonitrile over 15 min was used and much of the HPLC system was maintained at 0°C, including the solvent reservoirs, tubing, injector port, and C 18 column (24) . Deuterium incorporation in specific peptides was determined from the mass difference between the non-deuterated and deuterated peptide after correction for loss of deuterium during pepsin digestion and LC MS/MS analysis. Deuterium incorporation differences Ͻ5% were considered within experimental error of the methodology (25) . To estimate deuterium loss during digestion and analysis, fully deuterated samples were prepared by overnight incubation in D 2 O at 60°C then analyzed for m 100% in Equation 1 (27) ,
where m ϭ the mass of deuterated peptide, m 0% ϭ the mass of nondeuterated peptide and m 100% ϭ the mass of the fully deuterated peptide. The number of incorporated deuterium in peptides was calculated using Equation 2,
where N is the number of exchangeable peptide amide hydrogens. Structural Modeling-The sequence alignment of ␣TTP, SPF, and Sec14 presented by Hendrickson and co-workers (15) was used as a guide for locally written programs to superimpose the ligand binding domains of these structures (28) . These programs select residues for equivalence if the distance is within a cutoff threshold. In this method, the structures match well within the aligned region but may deviate outside those matched regions. In order to make a model of the ligand binding domain (CRALBP residues 143-301), the ␣TTP backbone and the residues that match in three structures were superimposed. With occupancy of 0.5 for ␣TTP and 0.25 for each of SPF and Sec14, the structures were placed in a box, and the space group assigned as P1. The CCP4 program sfall (29) was used to Fourier transform the three structures, and the format converted to that of XtalView (30) . The resolution chosen was to 2.8 Å. The structure factors and phases from the transform of the three structures were used as a probability density. The CRALBP residues of the alignment were fitted into this probability density using XtalView. The primitive CRALBP model was refined to the probability density using CNS (31) . The R-factor from this refinement was 0.30 and R-free was 0.33.
The CRALBP model was constructed in the ligand-bound form. The retinal schiff base was taken from the rhodopsin coordinates (1hzx) and converted to 11-cis-retinal. The 11-cis-retinal was oriented in the model by trial such that after refinement, the aldehyde group was solvent inaccessible (4, 9, 32) . In MOE (33) the model was flooded with water molecules, energy minimized and dynamics calculated for up to 1 ns. Following the dynamics (CHARMm22, 300 K, at constant temperature and volume) the energy was minimized to finish the process (28) . Model figures were drawn with Molscript (34) and Raster3d (35) .
RESULTS

rCRALBP Binds DK-11-cis-Retinal in the Ligand Binding
Pocket-To determine whether rCRALBP binds the photoaffinity reagent in a similar manner as endogenous ligands, the purified apoprotein was incubated with either DK-11-cis-retinal or 11-cis-retinal, excess unbound retinoid removed and UV-visible spectral analyses performed. Spectral analyses of the holoprotein complexes are shown in Fig. 2 , along with the molecular structures of the two ligands and absorbance spectra of the free retinoids. DK-11-cis-retinal exhibits a bathochromic absorbance shift from 380 to ϳ408 nm when complexed with human rCRALBP, yielding a chromophore maxima between that of the holoprotein with bound 11-cis-retinal ( max ϭ 425 nm) or 9-cis-retinal ( max ϭ 400 nm). Upon bleaching of CRALBP bound DK-11-cis-retinal with white light, the absorption maxima of the photoaffinity reagent shifts to ϳ380 nm because of the production of free, all-trans-retinoid. These results support a specific interaction between DK-11-cis-retinal and the rCRALBP ligand binding pocket.
Photoaffinity Labeling of rCRALBP-To covalently label rCRALBP, the DK-11-cis-retinal-rCRALBP complex was irradiated with UV light and bound retinal was reduced with tritiated sodium borohydride to provide a radioactive marker at the sites of modification. Preliminary experiments (Supplemental Fig. 1 ) using 20 min of photolysis as described for photolabeling rhodopsin (11) yielded about 4 mol% 3 H incorporation in rCRALBP and significant nonspecific protein modification (data not shown). Photolysis times of 5-40 s yielded a relatively constant ϳ1 mol% 3 H incorporation (Supplemental Fig. 1 ) therefore 5 s photolysis was used for preparative procedures to minimize nonspecific labeling. Notably, UV-visible spectra of the preparation following 5 s photolysis at 254 nm but prior to reduction with NaB[
3 H] 4 were essentially the same as after bleaching with white light for 20 min (Fig. 2B) , suggesting that photolysis isomerized most of the ligand to intact Identification of Photoaffinity Modification Sites in rCRALBP-To identify photoaffinity modified amino acid residues, [ 3 H]DK-rCRALBP (5 nmol) was digested with trypsin, peptides fractionated by RP-HPLC (Fig. 4) , and all chromatography fractions were analyzed by LC MS/MS. Ten peptides were detected in the four radioactive pools and were found to contain a total of eight modified residues, each with a different adduct mass addition (summarized in Table I and shown by individual mass spectra in Supplemental Fig. 2) . Mass spectrometric analyses of all other chromatography fractions accounted for the entire sequence of rCRALBP (Supplemental Table I ), and no other modified peptides were identified.
Identification of the rCRALBP Ligand Binding Pocket by H/D Exchange-
The exposure of rCRALBP to deuterium resulted in a time-dependent increase in the mass of both aporCRALBP and rCRALBP complexed with 11-cis-retinal (Supplemental Fig. 3 ). After 20 s in D 2 O, the number of deuterium incorporated in apo-rCRALBP increased to 108 and in holorCRALBP to 121. After 60 s in D 2 O, no difference in H/D exchange between apo and holo-rCRALBP was detectable and the protein masses did not increase further (Supplemental Fig.  3 ). Therefore, a D 2 O exposure time of 20 s was chosen as appropriate for topological analysis. The reproducibility of the methodology was evaluated by LC ESMS analysis of five different intact apo-rCRALBP samples (100 pmol each) following 20 s in D 2 O, and the average deuterium incorporation determined to be 106.6 Ϯ 1% relative S.D. (data not shown).
Unambiguous identification of peptic peptides covering most (92%) of the CRALBP sequence was established by tandem mass spectrometry prior to H/D exchange (Supplemental Table  II ). Also prior to topological analyses, the reproducibility of deuterium incorporation in six different peptides was evaluated by LC ESMS analysis of five separate preparations of apo-rCRALBP (100 pmol each) following 20 s in D 2 O and peptic digestion. In these analyses, the average deuterium incorporation per peptide exhibited a mean relative S.D. of ϳ2.6% (data not shown). Comparison of deuterium incorporation in specific peptides of the rCRALBP with and without bound ligand is summarized in Fig. 5 and itemized in detail in Supplemental  Table II . The central portion of rCRALBP (residues 111-197) incorporated relatively low levels of deuterium (ϳ30 -47%) and exhibited little difference in H/D exchange between the apoand holo-protein. The N and C termini of both structures exhibited moderate to high levels of deuterium exchange (ϳ54 -82%), suggesting that these regions are solvent exposed in both apo-and holo-rCRALBP. Ligand-dependent incorporation differences were found associated with N-terminal residues 5-42 and C-terminal residues 282-316, which incorporated significantly more deuterium in the holoprotein (Fig. 5 ) and therefore 
TABLE I Photoaffinity-modified amino acids in rCRALBP
The above eight photoaffinity-modified residues were identified by LC MS/MS analysis. Peptides accounting for 100% of the rCRALBP sequence were found in the chromatography fractions (Fig. 4) with modified residues only found in radioactive fractions. Four residues have been independently associated with the ligand binding pocket using other methods. are more solvent-exposed in the holoprotein. Residues 41-71, 80 -94, 127-137, and 262-275 also incorporated more deuterium in holo-rCRALBP. In contrast, residues 198 -255 incorporated significantly less deuterium in holo-rCRALBP, indicating that this region is less accessible to aqueous solvent when the ligand binding pocket is occupied. Notably CRALBP residues 197-255 contain 10 of 12 amino acids proposed to interact with ligand (2, 9, 10), including 7 of 8 photolabeled residues (Table I) .
Structural Model of the CRALBP Ligand Binding Cavity-A stereo diagram of the structural model determined for CRALBP with bound ligand is shown in Fig. 6 . The positioning of 11-cis-retinal within the ligand cavity of the model was determined by multiple energy minimization and dynamics calculations such that the aldehyde group was inaccessible to the aqueous environment (4, 9, 32) . Within the model, distances were calculated between ligand and all proposed components of the ligand cavity from previous biochemical analyses (Table II) 
DISCUSSION
The visual cycle is the enzymatic retinoid-processing pathway involved in regenerating bleached rod and cone visual pigments (for reviews see Refs. 1, 6, 36 -39) . In mammalian rods, photoisomerization converts rhodopsin-bound 11-cis-retinal to all-trans-retinal, which is reduced to all-trans-retinol within the photoreceptor outer segment. all-trans-Retinol leaves the rod photoreceptor cells and enters the adjacent RPE, where it is esterified by lecithin:retinol acyltransferase, converted to 11-cis-retinol by an isomerohydrolase, and oxidized to 11-cis-retinal by one or more short chain dehydrogenases. 11-cis-Retinal then leaves the RPE and re-enters the photoreceptor cell where it regenerates rhodopsin, completing the rod visual cycle. Less is known about cone visual pigment regeneration, but the process is different than for rhodopsin and may involve 11-cis-retinoid synthesis in Mü ller cells, which also express CRALBP (40) . In the RPE, CRALBP functions as an 11-cis-retinol acceptor for the isomerohydrolase and as a substrate carrier for 11-cis-retinol dehydrogenase (2-6). These functions require the rapid association and release of retinoid from the CRALBP ligand binding pocket. Previous studies have demonstrated high CRALBP binding affinity for 11-cis-retinal (K d Յ 21 nM) and that the protein preferentially binds 11-cisretinal over 11-cis-retinol (2, 9, 41). Toward a better understanding of CRALBP function, we are characterizing the structure of the retinoid binding pocket.
Structure-function studies first localized the CRALBP retinoid binding domain to C-terminal residues 120 -313 by limited proteolysis (42) . In subsequent work, the lack of covalent interactions between rCRALBP and retinoid was demonstrated and residues Gln 210 and Lys 221 associated with retinoid binding by a combination of protein chemical modifications, sitedirected mutagenesis, and UV-visible and fluorescence spectroscopy (9). More recently using similar methods combined with heteronuclear single quantum correlation NMR and enzymatic assays with purified recombinant 11-cis-retinol dehydrogenase, rCRALBP residues Trp 165 , Met 208 , Met 222 , Met 225 , and Trp 244 were found to influence retinoid binding and substrate carrier function. Most, if not all of these residues were found to undergo ligand-dependent conformational changes (10) . Also, disease-causing mutation R233W was found to significantly tighten retinoid affinity and to change the rCRALBP retinoid binding pocket conformation, suggesting residue 233 as part of or in close proximity to the retinoid binding cavity (2). In the present study, the CRALBP retinoid binding pocket has been further characterized by photoaffinity labeling, high resolution topological analysis, and structural modeling.
Photolabeling of the CRALBP Ligand Binding Pocket-CRALBP exhibits highly stereoselective ligand interactions in 1:1 stoichiometry with 11-cis-retinol, 11-cis-retinal, and 9-cisretinal, resulting in a red shift in ligand absorbance relative to the unbound ligand (41) . When complexed with CRALBP, the photoaffinity reagent DK-11-cis-retinal also exhibits a bathochromic absorbance shift, supporting a specific interaction with the ligand binding pocket. The chromophoric maximum of human rCRALBP-bound DK-11-cis-retinal (ϳ408 nm) approximates that of bovine CRALBP complexed with 9-cis-retinal (405 nm) (41) . Photolabeling of rCRALBP with DK-11-cis-retinal yielded covalent incorporation (1-4 mol%) consistent with the estimated labeling efficiency of rhodopsin with this analogue (0.7-1.5 mol%) (12) . To help stabilize the protein conformation, photolysis of rCRALBP was performed near Ϫ196°C in 67% glycerol, but in contrast to the 20 min rhodopsin photolabeling procedure (11, 12) , photolysis was limited to 5 s to achieve specific labeling. Even with only 5 s of photolysis, most of the DK-11-cis-retinal ligand appears to be isomerized to all-trans-retinoid for which rCRALBP has no affinity (41). About 1 mol% incorporation of photo-label was obtained in 5 nmol of rCRALBP (ϳ195 g) and a total of eight photoaffinitymodified rCRALBP residues were identified by mass spectrometry. The specificity of the labeling is supported by independent analyses (9, 10) 11-cis-retinal was that each of the modified residues in rCRALBP exhibited different adduct masses, and more than one mass addition per residue was detected for Met 222 and Val 223 . Photoaffinity labeling with diazo reagents involves photogeneration of a carbene group, which inserts into nearby polypeptide. A mass addition of 296 was expected after removal of the diazo group and covalent attachment of the otherwise intact retinoid analogue, however this adduct mass was not observed. Diazo reagents are highly labile as are retinoid reagents and the chemistry of the present photolabeling remains unclear. We speculate that upon UV-irradiation of rCRALBP bound DK-11-cis-retinal, the resulting carbene radical moves freely throughout the highly conjugated polyene structure of the retinoid analogue. We suspect fragmentation of the photolabel occurs at the time of attachment to the protein and assume that prior to insertion, the photoisomerized, intact 44) , another poorly understood mechanism. Hypothetical structures for four of the ten observed photo-adducts in rCRALBP are presented in Supplemental Fig. 4 ; however, the identity and molecular origin of all the modifications remain unknown. The sites modified in rhodopsin with radioactive DK-11-cis-retinal and in the ligand binding pocket of cellular retinoic acid-binding protein with all-trans-retinoic acid (44) were identified by Edman degradation. Their molecular identities have yet to be determined (11, 12) . Despite these uncertainties, the photoaffinity modifications in rCRALBP are localized within the retinoid binding cavity or at the entrance/exit of the pocket as shown by structural modeling.
The rCRALBP Ligand Binding Cavity Revealed by H/D Exchange-We also used H/D exchange detected by mass spectrometry to measure the effect of protein-bound 11-cis-retinal on the solvent accessibility of amide hydrogens (27) . Comparison of H/D exchange in intact apo-and holo-rCRALBP revealed about 10% more deuterium incorporation in the holoprotein, suggesting a more open, solvent exposed conformation for the protein with bound ligand. Comparison of H/D exchange in rCRALBP peptides indicated that the N and C termini are solvent exposed in both the apo-and holoproteins but more so with bound ligand. N-terminal residues 5-42, C-terminal residues 282-316, and residues 41-71, 80 -94, 122-137, and 262-275 all incorporated more deuterium in holo-rCRALBP and therefore are more solvent-exposed in the holoprotein. With the exception of residues 127-137, the central region of CRALBP (residues 111-197) incorporated low levels of deuterium with or without ligand and appears to be buried in both the apo-and holoprotein structures, perhaps forming the core of the folded protein. The only region of rCRALBP that incorporated significantly more deuterium in the absence of bound 11-cis-retinal encompasses amino acids 198 -255. This region contains most of the residues currently associated with ligand interactions by photoaffinity labeling and other biochemical analyses. These results are consistent with an earlier topological analyses using antibodies and protease that supports holo-rCRALBP residues 1-30, 100 -124, and 257-285 as being exposed and residues 30 -99 and 176 -229 as being inaccessible or buried (45) . The exposed regions of CRALBP constitute potential functional domains for interaction with other proteins and indeed the docking site for EBP50 has recently been shown to reside in the C-terminal four residues (8) .
Structural Modeling of the CRALBP Retinoid-binding Domain-The homology between CRALBP and other CRAL-TRIO family members (␣TTP, SPF, Sec14) spans ϳ185 amino acids and includes their respective ligand-binding pockets (13) . These CRALBP homologues are all cytosolic lipid-binding proteins and high resolution structures for all three have been determined by x-ray crystallography. Sec14 catalyzes exchange of phosphotidylinositol and phosphatidylcholine between membrane bilayers and is essential for yeast Golgi secretory function (16) . ␣TTP mediates the stereo-selective transfer of ␣-tocopherol into nascent VLDL in hepatocytes and plays a major role in maintaining human plasma ␣-tocopherol levels (14, 15) . SPF appears to be involved in cholesterol biosynthesis and squalene epoxidation in the liver but its natural ligand(s) and physiological role are unknown (17) . The crystal structures for ␣TTP were determined with and without ␣-tocopherol in the binding pocket, yielding similar structures except for a solventexposed "lid" or "mobile lipid-exchange loop" (residues 198 -221) that limits access to the ligand binding cavity (14) . Large conformational changes are required for entry or exit of ligand from the ␣TTP binding pocket (15) , consistent with the liganddependent conformational changes observed in CRALBP by NMR (10, 46) . SPF was crystallized with an unidentified ligand in the binding pocket and the determined structure resembles the liganded conformation of ␣TTP with the lid in the closed position (17) . The structure of Sec14 was determined with ␤-octylglucoside in the binding cavity and resembles the unliganded conformation of ␣TTP, with the lid open and part of the hydrophobic binding pocket exposed.
CRALBP retinoid binding pocket components are located within a highly homologous region of sequence containing the ligand binding cavities of other CRAL-TRIO family members (Fig. 7) . Notably, five of the CRALBP residues we have associated with the retinoid binding pocket (Trp 165 (14) is underlined, as are the homologous domains in SPF (17) and CRALBP.
